8-K: Bath & Body Works Exceeds Q1 Expectations, Narrows Full-Year Guidance
Quarterly Report
Bath & Body Works reported first quarter 2024 results with net sales and earnings per share exceeding guidance, leading to an improved full-year outlook.
Summary
- Bath & Body Works reported net sales of $1.384 billion for the first quarter of 2024, a slight decrease of 0.9% compared to $1.396 billion in the same period last year.
- The company's net sales were positively impacted by approximately 200 basis points due to a shifted fiscal calendar, but negatively impacted by 170 basis points due to weaker international results.
- Earnings per diluted share for Q1 2024 were $0.38, up from $0.35 in the prior year, and adjusted earnings per diluted share increased 15% to $0.38 from $0.33.
- Operating income for the quarter was $187 million, compared to $181 million last year, and net income was $87 million, up from $81 million.
- The company has narrowed its full-year 2024 net sales guidance to a range of -2.5% to flat compared to 2023, and expects earnings per diluted share to be between $3.05 and $3.35.
- Second quarter 2024 net sales are projected to decline between 2% and flat compared to the same period last year, with earnings per diluted share expected to be between $0.31 and $0.36.
- The full-year guidance includes an anticipated $300 million in share repurchases, and the second quarter guidance includes $75 million in share repurchases.
Sentiment
Score: 7
Explanation: The sentiment is positive due to the better-than-expected Q1 results and narrowed full-year guidance, but tempered by the slight decrease in net sales and weaker international performance.
Positives
- The company exceeded its own guidance for both net sales and earnings per share in the first quarter of 2024.
- Adjusted earnings per diluted share increased by 15% compared to the same period last year.
- The company is experiencing success with new product introductions and is seeing increased customer retention and loyalty.
- The full-year guidance has been narrowed and the midpoint has been raised for both top and bottom lines.
- The company is actively repurchasing shares, indicating confidence in its financial position.
Negatives
- Net sales decreased by 0.9% compared to the first quarter of 2023.
- The company experienced weaker than expected results in certain international markets.
- The company is forecasting a decline in net sales for the full year, ranging from 2.5% to flat compared to 2023.
- Second quarter earnings per diluted share are expected to be lower than the same period last year, with a range of $0.31 to $0.36 compared to $0.43.
Risks
- The company's performance is subject to general economic conditions, inflation, and consumer spending patterns.
- The company faces risks related to the seasonality of its business and its ability to manage labor costs.
- The company's international operations are subject to various risks, including political instability and currency fluctuations.
- The company relies on a limited number of suppliers and is exposed to risks related to supply chain disruptions.
- The company's ability to maintain the security of customer and company information is a risk.
Future Outlook
The company has narrowed its full-year guidance, raising the midpoint for both net sales and earnings per share, and anticipates continued share repurchases.
Management Comments
- We delivered a better-than-expected start to the year with net sales and earnings per share above the high-end of our guidance range.
- We are particularly excited with the success of our product introductions and newness, which drove the performance of both our core business and new adjacencies.
- Our focus on building strong brand awareness and engagement is delivering greater customer retention and loyalty.
- We remain confident in our ability to deliver long-term profitable growth.
Industry Context
The results reflect a mixed performance in the retail sector, with some companies experiencing growth while others face challenges. Bath & Body Works' focus on product innovation and customer engagement appears to be a positive strategy in a competitive market.
Comparison to Industry Standards
- Comparable companies in the personal care and home fragrance space include companies like L'Occitane, The Body Shop, and Yankee Candle.
- Bath & Body Works' Q1 performance, with a slight decrease in net sales but an increase in earnings per share, is mixed compared to some competitors who have reported stronger sales growth.
- The company's focus on share repurchases is a common strategy among mature retail companies to enhance shareholder value.
- The narrowing of full-year guidance suggests a more confident outlook compared to some peers who have maintained or lowered their guidance.
Stakeholder Impact
- Shareholders will likely react positively to the better-than-expected Q1 results and increased guidance.
- Employees may be encouraged by the company's positive performance and future outlook.
- Customers may benefit from the company's focus on product innovation and customer engagement.
- Suppliers may see continued business with the company due to its stable financial position.
Next Steps
- The company will conduct its first quarter earnings call on June 4.
- The company will continue to execute on its strategic initiatives.
- The company will continue to deploy cash towards share repurchases.
Key Dates
| Date | Description |
|---|---|
| April 29, 2023 | End of the first quarter of 2023 for comparison purposes. |
| May 4, 2024 | End of the first quarter of 2024. |
| June 4, 2024 | Date of the press release and earnings call. |
Keywords
Bath & Body Works, Financial Results, Earnings, Net Sales, Guidance, Share Repurchase, Retail, Consumer Goods
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.